ORPHAN

Pharmaceutical preparations for use in the treatment of orphan diseases, namely, diseases related to hematology, genetic disorders, infectious diseases, metabolic disorders, oncology, respiratory diseases, poison control, diseases affecting immunocompromised patients, urology, Tyrosinemia Type I, and kidney stones associated with metabolic etiology; medicines for human use, namely, medicines for the treatment of orphan diseases, namely, diseases related to hematology, genetic disorders, infectious diseases, metabolic disorders, oncology, respiratory diseases, poison control, diseases affecting immunocompromised patients, urology, Tyrosinemia Type I, and kidney stones associated with metabolic etiology; and pharmaceutical preparations and medicine for human use for treatment of pain